The Beauty Health Company Stock Price, News & Analysis

BeautyHealth (NASDAQ: SKIN) appointed Philippe Schaison, PharmaD to its Board of Directors, effective October 30, 2025. Schaison brings over 20 years of leadership across global aesthetics, biotech, and consumer health, including roles as CEO NA of Syneron Candela and President of Allergan Aesthetics, and current CEO of Soltégo, Inc.

He will join the Compensation and Nominating & Corporate Governance Committees. Following the appointment, the Board will total eight directors. The company said Schaison’s experience should help expand Hydrafacial’s global reach and accelerate category growth.

Beauty Health (NASDAQ:SKIN) will report third quarter 2025 financial results after market close on Thursday, November 6, 2025. The company will host an investor conference call at 4:30 p.m. Eastern Time following a press release that details the results.

A live webcast and supporting materials will be available on the company investor relations website at https://investors.beautyhealth.com. A recording of the call will be posted approximately three hours after the call concludes. The company discloses material information via SEC filings, press releases, public calls, and its investor relations website to comply with Regulation FD.

The Beauty Health Company (NASDAQ: SKIN) has appointed Pedro Malha as its new President and Chief Executive Officer, effective October 1, 2025. Malha, who brings over 20 years of experience in healthcare and medical devices, succeeds Marla Beck, who is stepping down but will remain in an advisory role.

Malha joins from Abbott Laboratories, where he served as Worldwide Division President and Corporate Officer leading the neuromodulation business. His prior experience includes senior leadership roles at Zimmer Biomet Holdings, Abbott, and Johnson & Johnson in Europe.

Under Beck's leadership, BeautyHealth underwent significant transformation, including strengthening its innovation pipeline, upgrading manufacturing and operations, improving margins, and maintaining Hydrafacial's position as a leading performance skin health brand.

BeautyHealth's (NASDAQ: SKIN) flagship brand Hydrafacial has achieved a significant milestone by entering Cosmopolitan's Readers' Choice Hall of Fame after winning Best Pro Facial for the third time. The company has garnered multiple prestigious awards in 2025, including recognition from ELLE, NewBeauty, and Good Housekeeping.

Hydrafacial demonstrates strong market leadership with 38% brand awareness and a global social media following of 1.3 million. The treatment's effectiveness is reflected in consumer loyalty, with 92% of clients stating they would switch estheticians if Hydrafacial treatments weren't available. The brand maintains the highest online engagement among aesthetic peers, driving client demand and provider growth.

The Beauty Health Company (NASDAQ:SKIN) has launched the Hydrafacial Advisory Councils and Ambassador Network, bringing together leading plastic surgeons, dermatologists, aesthetic practitioners, and estheticians to guide the company's future development.

The initiative aims to enhance product innovation, education programs, and clinical research through real-world insights. The councils will be led by three inaugural chairs: Ted Lain, MD, MBA; Blaklee Paige Smith, MSN, APRN; and Kelly Horton-Beeman, LE.

This strategic move builds upon Hydrafacial's existing professional development initiatives, including their HFX Training Programs which have trained over 60,000 providers globally. The company also maintains partnerships with various professional organizations and offers scholarship programs for estheticians.

The Beauty Health Company (NASDAQ:SKIN), owner of Hydrafacial™, has launched its Hydrafacial Advisory Councils and Ambassador Network, comprising leading plastic surgeons, dermatologists, aesthetic practitioners, and estheticians. The initiative aims to enhance product development, education, and clinical excellence.

Led by CEO Marla Beck, the program features inaugural council chairs including Ted Lain, MD, MBA, Blaklee Paige Smith, and Kelly Horton-Beeman. The councils will guide innovation, treatment protocols, and clinical research while supporting peer-to-peer learning initiatives. This strategic move builds upon Hydrafacial's existing provider support programs, including their HFX Training Programs which have trained over 60,000 providers globally.

BeautyHealth (NASDAQ: SKIN) reported Q2 2025 financial results, showing mixed performance with net sales of $78.2 million, down 13.7% year-over-year, but improved profitability metrics. The company achieved net income of $19.7 million, up from $0.2 million in Q2 2024, and Adjusted EBITDA of $13.9 million compared to $(5.2) million last year.

Key highlights include gross margin improvement to 62.8% (vs 45.2% in Q2 2024), successful debt restructuring, and an active install base of 35,193 units. The company raised its 2025 guidance, projecting net sales of $285-300 million and Adjusted EBITDA of $27-35 million. BeautyHealth also successfully launched HydraFillic with Pep9™ Booster and reported strong consumables performance, representing over 70% of revenue.

["Net income increased significantly to $19.7M from $0.2M YoY", "Gross margin improved to 62.8% from 45.2% YoY", "Adjusted EBITDA turned positive to $13.9M from $(5.2)M YoY", "Consumables now represent over 70% of revenue, showing recurring revenue strength", "Raised full-year 2025 guidance", "Successfully restructured debt obligations"]

BeautyHealth (NASDAQ:SKIN), the company behind Hydrafacial™, has scheduled its second quarter 2025 financial results announcement for August 7, 2025, after market close. The company will host an investor conference call at 4:30 p.m. Eastern Time to discuss the results.

Investors can access the live webcast and supporting materials through BeautyHealth's investor relations website. A recording will be available approximately three hours after the call concludes.

The Beauty Health Company (NASDAQ:SKIN) has launched HydraFillic with Pep9™ Booster, a new peptide-powered skin treatment for their Hydrafacial brand. The innovative booster features a proprietary complex of nine peptides clinically proven to improve fine lines, wrinkles, and skin firmness. Clinical testing demonstrated significant improvements in skin firmness, elasticity, hydration, and barrier health. Consumer perception data showed impressive results with 100% reporting improved skin firmness, 96% noting enhanced skin glow, and 93% experiencing tighter, smoother, and deeply hydrated skin. The product combines Pep9™ complex, Triple Hyaluronic Acid Complex, and fruit extracts with Vitamin B5. Hydrafacial's treatment system, which includes seven skin therapies, maintains a strong market presence with over 35,000 active devices globally.